CN Mobile Logo

Search form


MB07133 gets orphan drug status

MB07133 gets orphan drug status

SAN DIEGO¬óMetabasis Therapeutics' MB07133 has received orphan drug status from FDA for the treatment of hepatocellular carcinoma. MB07133 is a novel HepDirect prodrug of cytarabine monophosphate designed to produce the oncolytically active form, cytarabine triphosphate, in the liver tumor where it acts to inhibit cell proliferation and induce apoptosis.

Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.